Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 9 results.
User Information
Export Records
  1. 1.   Anti-tumor efficacy of naked siRNAs for ERBB3 or AKT2 against lung adenocarcinoma cell xenografts
  2. Sithanandam, G.; Fornwald, L. W.; Fields, J. R.; Morris, N. L.; Anderson, L. M.
  3. International Journal of Cancer. 2012, Jan; 130(2): 251-258.
  1. 2.   Imidazo[2,1-b]thiazole guanylhydrazones as RSK2 inhibitors [1]
  2. Andreani, A.; Granaiola, M.; Leoni, A.; Locatelli, A.; Morigi, R.; Rambaldi, M.; Varoli, L.; Lannigan, D.; Smith, J.; Scudiero, D.; Kondapaka, S.; Shoemaker, R. H.
  3. European Journal of Medicinal Chemistry. 2011, Sep; 46(9): 4311-4323.
  1. 3.   Association of Single-Nucleotide Polymorphisms in JAK3, STAT4, and STAT6 With New Cardiovascular Events in Incident Dialysis Patients
  2. Sperati, C. J.; Parekh, R. S.; Berthier-Schaad, Y.; Jaar, B. G.; Plantinga, L.; Fink, N.; Powe, N. R.; Smith, M. W.; Coresh, J.; Kao, W.
  3. American Journal of Kidney Diseases. 2009 53(5): 845-855.
  1. 4.   Activating Met mutations produce unique tumor profiles in mice with selective duplication of the mutant allele
  2. Graveel, C.; Su, Y. L.; Koeman, J.; Wang, L. M.; Tessarollo, L.; Fiscella, M.; Birchmeier, C.; Swiatek, P.; Bronson, R.; Woude, G. V.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2004, DEC 7; 101(49): 17198-17203.
  1. 5.   Early onset hereditary papillary renal carcinoma: Germline missense mutations in the tyrosine kinase domain of the met proto-oncogene
  2. Schmidt, L. S.; Nickerson, M. L.; Angeloni, D.; Glenn, G. M.; Walther, M. M.; Albert, P. S.; Warren, M. B.; Choyke, P. L.; Torres-Cabala, C. A.; Merino, M. J.; Brunet, J.; Berez, V.; Borras, J.; Sesia, G.; Middelton, L.; Phillips, J. L.; Stolle, C.; Zbar, B.; Pautler, S. E.; Linehan, W. M.
  3. Journal of Urology. 2004, OCT; 172(4): 1256-1261.
  1. 6.   Genetic basis of cancer of the kidney: Disease specific approaches to therapy
  2. Linehan, W. M.; Vasselli, J.; Srinivasan, R.; Walther, M. M.; Merino, M.; Choyke, P.; Vocke, C.; Schmidt, L.; Isaacs, J. S.; Glenn, G.; Toro, J.; Zbar, B.; Bottaro, D.; Neckers, L.
  3. Clinical Cancer Research. 2004, SEP 15; 10(18, Part 2 Suppl. S): 6282S-6289S.
  1. 7.   Tyrosine phosphorylation of the Janus kinase 2 activation loop is essential for a high-activity catalytic state but dispensable for a basal catalytic state
  2. Chatti, K.; Farrar, W. L.; Duhe, R. J.
  3. Biochemistry. 2004 43(14): 4272-4283.
  1. 8.   Novel mutations of the MET proto-oncogene in papillary renal carcinomas
  2. Schmidt, L.; Junker, K.; Nakaigawa, N.; Kinjerski, T.; Weirich, G.; Miller, M.; Lubensky, I.; Neumann, H. P. H.; Brauch, H.; Decker, J.; Vocke, C.; Brown, J. A.; Jenkins, R.; Richard, S.; Bergerheim, U.; Gerrard, B.; Dean, M.; Linehan, W. M.; Zbar, B.
  3. Oncogene. 1999 18(14): 2343-2350.
  1. 9.   Autophosphorylation of Activation Loop Tyrosines Regulates Signaling By the Trk Nerve Growth Factor Receptor
  2. Cunningham, M. E.; Stephens, R. M.; Kaplan, D. R.; Greene, L. A.
  3. Journal of Biological Chemistry. 1997 272(16): 10957-10967.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel